Pharmacotherapy
-
Randomized Controlled Trial Clinical Trial
Pharmacokinetics of meropenem 0.5 and 2 g every 8 hours as a 3-hour infusion.
To assess the pharmacokinetics of meropenem administered as a 3-hour infusion. ⋯ Prolonging the percentage of time above the minimum inhibitory concentration is a feasible option with meropenem; however, further studies are needed to quantify how this increase translates to efficacy.